BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
11 mars 2025 07h30 HE
|
BrainsWay
Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year 2024 revenue increased nearly 30% YoY to $41 million Exceeded full year 2024 operating...
BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
04 mars 2025 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, March 04, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
24 févr. 2025 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Israel, Feb. 24, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive...
BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
12 déc. 2024 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of...
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
20 nov. 2024 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive...
BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights
12 nov. 2024 07h30 HE
|
BrainsWay
Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance Conference Call to be Held Today at 8:30 AM ET ...
BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024
29 oct. 2024 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
09 oct. 2024 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive...
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
30 sept. 2024 07h30 HE
|
BrainsWay
Company to leverage capital and Valor’s expertise for strategic initiatives building market awareness, R&D roadmap, data analysis capabilities, and expanding access to Deep TMS™ Purchase price of...
BrainsWay Announces Significant Expansion on U.S. East Coast
16 sept. 2024 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Sept. 16, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...